Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Trastuzumab vs Observation in Breast Cancer
NCT00533936Phase 2Unknown
- Sponsor
- Instituto Nacional de Cancerología
- Start
- Sep 2006
- Primary completion
- Dec 2009
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by Instituto Nacional de Cancerología. Status: unknown.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00533936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533936.